IL171893A0 - Dispersible pharmaceutical composition for treatment of mastitis and otic disorders - Google Patents
Dispersible pharmaceutical composition for treatment of mastitis and otic disordersInfo
- Publication number
- IL171893A0 IL171893A0 IL171893A IL17189305A IL171893A0 IL 171893 A0 IL171893 A0 IL 171893A0 IL 171893 A IL171893 A IL 171893A IL 17189305 A IL17189305 A IL 17189305A IL 171893 A0 IL171893 A0 IL 171893A0
- Authority
- IL
- Israel
- Prior art keywords
- mastitis
- treatment
- pharmaceutical composition
- otic disorders
- dispersible pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0041—Mammary glands, e.g. breasts, udder; Intramammary administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Packages (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49217803P | 2003-07-31 | 2003-07-31 | |
PCT/IB2004/002474 WO2005009472A2 (en) | 2003-07-31 | 2004-07-19 | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
IL171893A0 true IL171893A0 (en) | 2006-04-10 |
Family
ID=34103028
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL171893A IL171893A0 (en) | 2003-07-31 | 2005-11-10 | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1656159A2 (en) |
JP (1) | JP2007500692A (en) |
KR (1) | KR100807414B1 (en) |
CN (1) | CN1812814A (en) |
AU (1) | AU2004258746A1 (en) |
BR (1) | BRPI0412923A (en) |
CA (1) | CA2529405A1 (en) |
IL (1) | IL171893A0 (en) |
MX (1) | MXPA06001192A (en) |
NO (1) | NO20055466L (en) |
RU (1) | RU2329064C2 (en) |
WO (1) | WO2005009472A2 (en) |
ZA (1) | ZA200600850B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA06012215A (en) * | 2004-04-22 | 2007-04-19 | Pfizer Prod Inc | Method of stabilizing disordered cefovecin sodium salt. |
WO2014001353A1 (en) * | 2012-06-29 | 2014-01-03 | Bayer Animalhealth Gmbh | Pharmaceutical compositions and treatment of mastitis |
MX2016001912A (en) * | 2013-08-12 | 2016-06-02 | Novartis Ag | Method for treating otic infections after tympanostomy tube placement. |
CN104622875B (en) * | 2015-02-12 | 2017-05-10 | 江西博莱大药厂有限公司 | Breast injection medicament for resisting cow mastitis and preparation method thereof |
AU2016350868B2 (en) * | 2015-11-03 | 2022-03-31 | Zoetis Services Llc | Sol-gel polymer composites and uses thereof |
RU2663070C1 (en) * | 2017-05-04 | 2018-08-01 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Method for otomycosis treatment |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0782448T3 (en) * | 1995-06-06 | 2002-07-08 | Bayer Ag | Non-irritating, non-sensitizing, non-ototoxic antibacterial ear preparations |
US5736151A (en) * | 1996-12-09 | 1998-04-07 | Pharmacia & Upjohn Company | Antibiotic oil suspensions |
US20010049366A1 (en) * | 2000-02-09 | 2001-12-06 | Alcon Universal Ltd. | Topical solution formulations containing an antibiotic and a corticosteroid |
-
2004
- 2004-07-19 RU RU2006102665/14A patent/RU2329064C2/en not_active IP Right Cessation
- 2004-07-19 CA CA002529405A patent/CA2529405A1/en not_active Abandoned
- 2004-07-19 CN CNA2004800183007A patent/CN1812814A/en active Pending
- 2004-07-19 JP JP2006521704A patent/JP2007500692A/en not_active Abandoned
- 2004-07-19 WO PCT/IB2004/002474 patent/WO2005009472A2/en active Application Filing
- 2004-07-19 AU AU2004258746A patent/AU2004258746A1/en not_active Abandoned
- 2004-07-19 KR KR1020067002174A patent/KR100807414B1/en not_active IP Right Cessation
- 2004-07-19 BR BRPI0412923-7A patent/BRPI0412923A/en not_active IP Right Cessation
- 2004-07-19 MX MXPA06001192A patent/MXPA06001192A/en unknown
- 2004-07-19 EP EP04744125A patent/EP1656159A2/en not_active Withdrawn
-
2005
- 2005-11-10 IL IL171893A patent/IL171893A0/en unknown
- 2005-11-18 NO NO20055466A patent/NO20055466L/en not_active Application Discontinuation
-
2006
- 2006-01-30 ZA ZA200600850A patent/ZA200600850B/en unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA06001192A (en) | 2006-04-11 |
AU2004258746A1 (en) | 2005-02-03 |
JP2007500692A (en) | 2007-01-18 |
WO2005009472A3 (en) | 2005-04-07 |
RU2006102665A (en) | 2006-06-10 |
CA2529405A1 (en) | 2005-02-03 |
BRPI0412923A (en) | 2006-09-26 |
KR20060033031A (en) | 2006-04-18 |
RU2329064C2 (en) | 2008-07-20 |
KR100807414B1 (en) | 2008-02-25 |
WO2005009472A2 (en) | 2005-02-03 |
NO20055466L (en) | 2006-04-21 |
EP1656159A2 (en) | 2006-05-17 |
CN1812814A (en) | 2006-08-02 |
NO20055466D0 (en) | 2005-11-18 |
ZA200600850B (en) | 2007-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1644021E (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
IL175529A0 (en) | Methods and compositions for the treatment of metabolic disorders | |
ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
IL157734A0 (en) | Pharmaceutical compositions for the treatment of urogenital disorders | |
PT2359856T (en) | Formulation of human antibodies for treating tnf-alpha associated disorders | |
EP1737453A4 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of skin diseases or disorders | |
IL178730A0 (en) | New pharmaceutical compositions for the treatment of sexual disorders ii | |
IL177772A0 (en) | Methods and compositions for the treatment of gastrointestinal disorders | |
IL175425A0 (en) | Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders | |
AU2002252373A1 (en) | Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders | |
EP1699431A4 (en) | Compositions for treatment of ear disorders and methods of use thereof | |
HUP0600781A2 (en) | Compounds for the treatment of metabolic disorders and pharmaceutical compositions containing them | |
HUP0202719A3 (en) | Pharmaceutical compositions for the treatment of female sexual dysfunctions | |
ZA200707934B (en) | Thereapeutic formulations for the treatment of beta-amyloid related diseases | |
AU2003286741A8 (en) | Methods and compositions for diagnosis and therapy of parkin-associated disorders | |
EP1638938A4 (en) | Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases | |
EP1680145A4 (en) | Methods and compositions for the treatment of neurological disease | |
EP1648417A4 (en) | Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders | |
IL171893A0 (en) | Dispersible pharmaceutical composition for treatment of mastitis and otic disorders | |
EP1478438A4 (en) | Methods and compositions for the treatment of asthma and related disorders | |
EP1651255A4 (en) | Topical veterinary compositions and methods for the treatment and prevention of infection | |
PL371281A1 (en) | Methods and compositions for the treatment of eye diseases | |
AU2002362115A1 (en) | Composition and methods for treatment of neurological disorders | |
TWI347845B (en) | Pharmaceutical compositions,combinations,and kits for the treatment of respiratory diseases and use of the same | |
EP1660101A4 (en) | Liquid formulations for the prevention and treatment of mucosal diseases and disorders |